Ticker Launch

SPAC · Merger completed

Bellevue Life Sciences Acquisition Corp.

Business combination with OSR Holdings Co., Ltd.

Bellevue Life Sciences Acquisition Corp. is a blank-check company (SPAC) that raised $60M in its initial public offering on Feb 13, 2023, listing on Nasdaq Capital Market. It completed its business combination with OSR Holdings Co., Ltd. on Feb 14, 2025; the combined company is OSR Holdings, Inc. (now OSR Health, Inc.) (OSRH). K&L Gates advised the SPAC and Kirkland & Ellis advised the underwriters on the IPO.

Status
Merger completed
IPO date
Feb 13, 2023
IPO size
$60M
IPO exchange
Nasdaq Capital Market
Target
OSR Holdings Co., Ltd. (Korea)
Announced
Nov 16, 2023
Stated deal value
$244.6M
Closed
Feb 14, 2025
Combined company
OSR Holdings, Inc. (now OSR Health, Inc.) (OSRH)
SPAC counsel (IPO)
K&L Gates
Underwriters' counsel (IPO)
Kirkland & Ellis

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2025